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Summary: The efficacy of various Substrates for measuring serum choline esterase for the evaluation of
hepatic function was studied using 0-toluoyl- and succinyl-choline, and acetyl, butyryl- and propionyl-
thiocholine. In hepatic disease, the serum choline esterase activity with these Substrates was decreased at a
similar rate, showing no significant difference. In 78 — 84% of cases with hepatic cirrhosis the enzyme activity
with these Substrates was less than 50% of the average level of normal individuals, but in acute and chronic
hepatitis only 4—9 and 12—14% of patients showed these lower values, respectively. The present study
indicates the usefulness of sequential monitoring of serum choline esterase activity with any of these Substrates
for assessing hepatic disease, particularly cirrhosis, and for monitoring the course of hepatic disease.
Vergleich von Substraten zur Messung von Cholinesterase im Serum bei hepato-biliären Erkrankungen
Zusammenfassung: 0-Toluoyl- und Succinylcholin sowie Acetyl-, Butyryl- und Propionylthiocholin wurden
hinsichtlich ihrer Wirksamkeit als Substrat für die Bestimmung von Cholinesterase zur Bewertung der
Leberfunktion untersucht. Bei Lebererkrankungen war die mit diesen Substraten gemessene katalytische
Konzentration von Cholinesterase im Serum in gleichem Maße verringert, es gab keine signifikanten Unter-
schiede. Bei 78 — 84% der Fälle von Lebercirrhose betrug die mit diesen Substraten gemessene katalytische
Konzentration weniger als 50% des Referenzwertes Gesunder; bei akuter und chronischer Hepatitis jedoch
zeigten nur 4—9% bzw. 12—14% der Patienten diese niedrigen Werte. Die vorgelegte Untersuchung zeigt
den Nutzen der Bestimmung der katalytischen Aktivität von Cholinesterase mit jedem der Substrate für die
Feststellung von Lebererkrankungen, besonders Cirrhose, und für deren Verlaufskontrolle.
ntro uction in the surgjcal treatment of cirrhotic
The determination of plasma choline esterase (EC patients with portocaval or lienorenal anastomosis,
3.1:1 .8) activity is cliriically useful for evaluating cer- assays of serum choline esterase and albumin are very
tain pathological conditions: important for evaluating the prognosis of patients
. , . . f j f r before Operation and during the follow up period (4).First, its low activity could be the consequence of ̂  ̂ .̂  esterase has ̂  proyed w
reduced protem synthesis due to pathological caüse ^ as ^ of ̂  transplant cases (5).
such as liver cirrhosis, cancef, or malnutntion;
, ., . . . ,. . r Succinylcholine has been recommended for the id-second, there may be enzyme Inhibition, indicative of entification of the atypical variant of serum choline
organophosphate poisomng; pr esterase (6-9) propionylthiocholine has also been
third, low activity could indicate a genetic variant in recommended as a more useful Substrate than ben-
a perfectly healthy subject (1-3). zoylcholine, acetyl- or butyryl-thiocholine (10-12),
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although there is controversy (13). In addition, assay
at 37 °C is considered to be better than at lower
temperature such äs 25 °C (2).
On the other band, for assessing hepatic function
no significant difference among acetyl-, butyryl- and
propionyl-thiocholine was demonstrated by studying
choline esterase activity at 25 °C (14). At present, no
comparative study is available with respect to assay
temperature for the evaluation of hepatic function.
Recently, 0-toluoylcholine was reported to be a more
specific Substrate for the assay of serum pseu-
docholine esterase (l 5), but its clinical significance is
not known. Although succinylcholine is presumed to
be the most useful Substrate for detecting the atypical
variant of serum pseudocholine esterase (6), its ef-
ficacy for assessing hepatic function is also not
known.
To obtain further Information concerning the efficacy
of 0-toluoylcholine and succinylcholine for measuring
serum choline esterase activity in the assessment of
hepatic function, enzyme activities with these sub-
strates were studied in various sera at 25 °C and
37 °C, and compared with the activities obtained with
acetyl-, butyryl- and propionyl-thiocholine.
Materials and Methods
Mater ia l s
o-Toluoylcholine and succinylchojine Chloride were purchased
from Kyowa Hakko Kyogyo Co., and Tokyo Kasei Chem.
Co., respectively. Choline oxidase, peroxidase, phenol and 4-
aminoantipyrine (6, 15) were obtained from Kyowa Hakko
Kyogyo Co. Acetyl-, butyryl-, and propionyl-thiocholine
iodide, 2,2'-dithiodipyridine (16) and the other regents used
were purchased from Nakarai Chem. Co., Japan.
Methods
Patients with hepatic disease at various stages visited our clinic
from January to December, 1979, and were studied at randqm
with respect to serum choline esterase activity. The diagnosis
of 179 patients with hepatic disease was made by clinical,
biochemical and histological examination, and by computed
tomography, scintigraphy and ultrasound sonication. Of these,
140 patients satisfied predicted criteria for chronic non-active
and active liver disease (17 — 21), and also revealed these dis-
orders by morphological evaluation (22—24).
The activity of serum choline esterase was measured by the rate
assay method previously described, using acetyl-, butyryl-, or
propionyl-thiocholine at a concentration 12.5 mmol/1 at 37 °C.
2,2'-Dithiodipyridine was used äs the chromogenic reagent for
estimating thiocholine liberated from the Substrate (16). The
activity was also determined with 0-toluoylcholine, 0.5 mmol/1,
and succinylcholine, 0.5 mmol/1, by estimating choline liberated
from these Substrates using choline oxidase and a coupled
enzyme System at 37 °C (6, 15).
Results
Effect of Substrate concentration on choline esterase
activity in serum of normal subjects and in patients
with hepatic cirrhosis; Km values for various Substrates
With increasing Substrate concentrations of acetyl-,
butyryl-, and propionyl-thiochbline, the measured
choline esterase activity in serum increased, feaching
a plateau at 4 to 9 mmol/1 in normal serum and 2.5
to 3 mmol/1 in cirrhotic serum. With 0-toluoyl-choline,
activity became maximal at aböut 0.4 mmol/1 in both
groups. The Km of serum choline esterase was studied
on 5 normal individuals and 5 patients with hepatic
cirrhosis. The average Values of the KA of this enzyme
in normal serum for acetyl-, butyryl-, and propionyl-
thiocholine and o-toluoylcholine were 0.1, 0.098,
0.076 and 0.39 mmol/1, respectively, under the con-
ditions of this study. The corresponding values for
serum from patients with hepatic cirrhosis were 0.102,
0.093, 0.070 and 0.035 inmol/1, respectively, showing
no significant difference from those of normal indivi-
duals (figs. l and 2).
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Fig. 1. Lineweaver-Burk plots for serum choline esterase in
normal subjects and in patients with hepatic cirrhosis.
The average values of 5 experiments carried out using
sera from normal subjects and hepatic cirrhosis patients
are presented.
Normal subjects and hepatic cirrhosis
with acetylthiocholine o, butyrylthiocholine A and pro-
pionylthiocholine D.
Effect of temperature and incubation time on serum
choline esterase assay
Increasing the assay temperature from 25 to 37 °C
enhanced the enzyme activity. Performance of the
assay with propionylthiocholine at 37 °C for a longer
incubation time than 7 to 8 min did-not give accurate
results under the conditions of this method, owing to
non-linearity between enzyme activity and incubation
time (fig. 3). However, shorter incubation times, e. g.
5 min, resulted in accurate determinatioris.
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Fig. 2. Line\vcaver-Burk plots for serum choline esterase in
normal subjects and in patients with hepatic cirrhosis,
using o-toluoylcholine s Substrate. The average values
of 5 experiments carried out using sera from normal
subjects and hepatic cirrhosis patients are presented.
Normal subjects --- , hepatic cirrhosis - .
Using acetyl-, butyryl-, propionyl-thiocholine or o-
toluoylcholine, serum choline esterase activity in
patients with hepatic cirrhosis measured at 25 or
37 °C was significantly decreased compared with that
in normal individuals (p < 0.01, tab. 1). The average
serum enzyme levels in patients with hepatic cirrhosis,
measured with 0-toluoylcholine at 25, 30, and 37 °C
were about 29, 31 and 31% of the average levels of
normal serum, respectively (tab. 1). Similarly, with
acetylthiocholine s Substrate, the corresponding va-
lues were 31, 33, and 32% of the respective average
levels of normal serum (tab. 1). Similar results were
also obtained with butyryl- and propionyl-thio-
choline (tab. 1). These ratios of the activity at va-




Fig. 3. Effect of temperature and incubation time on serum
choline esterase activity.
With acetylthiocholine o, butyrylthiocholine A, and
propionylthiocholine D at 37 °C and
25°C — —.
With a short period of incubation, e. g. 5 min, the
difference in serum enzyme activity between normal
subjects and patients with hepatic cirrhosis was
greater at 37 °C than at 25 °C (tab. 1). However, at
a lower temperature such s 25 °C, and with a longer
period of incubation, e. g. 10 min, a better Separation
of enzyme activity in serum of normal subjects and
in patients with hepatic cirrhosis was obtained, show-
ing no significant difference compared with the results
assayed at 37 °C with a short period of incubation.
Tab. 1. Effect of temperature on serum choline esterase activity with various Substrates.
Figures in parentheses are activity fraction referred to the corresponding normal values.
Enzyme catalytic activity concentration, Substrate hydrolysed
[μίήοΐ/s · 1] (χ ± SD)































10.7 + 4.8 (0.31)
14.7 ± 5.2 (0.33)






20.8 ± 10.5 (0.32)








26.5 ± 10.7 (0.32)
34.3 ± 11.5(0.32)
1.75 ± 1.04
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Serum choline es l er se levels with various Substrates
in normal subjects and patients with various hepatic
diseases
In experiment l, the enzyme activity with 0-
toluoylcholine s Substrate was assayed at 37 °C and
compared with the measured activjties against acetyl-,
butyryl-, and propionyl-thiocholine. No significant
difference in the average values with all these sub-
strates was observed between normal individuals and
patients with acute or chronic hepatitis (p > 0.1),
though enzyme activity tended to decrease in patients
with chronic active hepatitis (tab. 2). However, in
hepatic cirrhosis a marked decrease in enzyme activity
with all these Substrates was observed (p < 0.01). A
significant difference was observed between acute or
chronic hepatitis and hepatic cirrhosis (p < 0.01
in each choline esterase catalytic concentration). In
primary and secondary hepatic carcinoma these en-
zyme activities were also decreased, being at levels
similar to thpse of hepatic cirrhosis (tab. 2). In benign
cholestatic disorders, these choline esterase activities
were within normal limits (tab. 2). The decreased
rates of the enzyme activity with these various sub-
strates in hepatic disorders were not significantly
different (p > 0.1, tab. 2).
In experiment 2, the serum enzyme activity against
succinylcholiiie in hepatic disease determined at 37 °C
was compared with that against acetyl-, butyryl·, and
propionyl-thiocholine. The serum enzyme activity
against succinylcholine was markedly decreased in
the serum of patients with hepatic cirrhosis (p <
0.01, tab. 3). The decreased rate of the enzyme activity
against succinylcholine in 'hepatic cirrhosis was not
significantly different from that for other Substrates
(p > 0.1, tab. 3).
A good correlation was observed between the enzyme
activities for these different Substrates in Various sera
(fig. 4).
Frequency of abnormalities of serum choline esterase
activity in chronic liver disease
In various hepatic disorders, particularly in hepatic
cirrhosis and carcinoma, lower values of choline
esterase were observed (tab. 2 and 3). Therefore, an
attempt was made to determine the discriminating
level for the differentiation of chronic active hepatic
disease from other hepatie disease.
Tab. 2. Serum choline esterase activity (37 °C) with various Substrates in normal subjects and in patients with hepatic disease.
Enzyme catalytic activity concentration, Substrate hydrolysed
[μιηοΐ/s · 1] (χ ± SD) '* "
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Tab. 3. Serum choline esterase activity (37 °C) with various Substrates in normal subjects and in patients with hepatic disease.
Enzyme catalytic activity concentration, Substrate hydrolysed
[μιηοΐ/s · 1] (χ ± SD)
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Acetylthiocholine. hydrolyzed
Fig. 4. Correlation between the serum activities of choline
esterase, measured with acetylthiocholine s Substrate
and with various other Substrates.
a) Substrate: butyrylthiocholine (normal Δ, hcpatitis
Δ, hepatic cirrhosis Δ)
n = 30, r = 0.96 (p < 0.001), y = 1.46x
- 5.25
Substrate: propionylthiocholine (normal D, hepa-
titis Q, hepatic cirrhosis a)
n = 30, r = 0.99 (p < 0.001), y = 1.89x
- 6.73.
b) Substrate: o-toluoylcholine (normal o, hepatitis o,
hepatic cirrhosis o)
n = 30, r = 0.98 (p < 0.001), y =
0.134x - 0.68.
Substrate: succinylcholine (normal V, hepatitis V,
hepatic cirrhosis V)
n = 30, r = 0.94 (p < 0.001), y =
0.019x - 0.035.
An enzyme activity against acetylthiocholine below
50% of the average level of normal subjects was seen
in l (4%) of 23 cases of acute hepatitis, 6 (12%) of
50 patients with chronic hepatitis and 25 (78%) of
32 patients with hepatic cirrhosis (tab. 4). With
butyrylthiocholine, a lower enzyme activity than 50%
of the average normal value was observed in 2 (8%)
of 23 cases of acute hepatitis, 7 (14%) of 50 chronic
hepatitis patients and 25 (78%) of 32 patients with
hepatic cirrhosis (Tab. 4). With propionyl-thiocho-
line, an activity below 50% of the average normal
level was found in l (4%) of 23 acute hepatitis, 6
(12%) of 50 chronic hepatitis and 25 (78%) of 32
hepatic cirrhosis patients (Tab. 4). With o-toluoylcho-
line an enzyme level lower than 50% of the average
normal value was found in 2 (9%) of 23 acute hepa-
titis, 6 (12%) of 50 chronic hepatitis, and 27 (84%)
of 32 hepatic cirrhosis patients (tab. 4).
In these 32 hepatic cirrhosis patients, 12 (37%) had
developed the disorder about a year previously, and
5 (16%), 3 (9%), 5 (16%) and 6 (19%) about 2, 3, 4
and 5 years previously, respectively, and one (3%)
had had the disorder for over 10 years. Of these, 18
(56%) were postnecrotic cirrhosis, 13 (41%) alco-
holic, and one (3%) biliary. In 7 cirrhosis patients
with relatively higher choline esterase activity, 4
showed the onset of disease 1—2 years ago, and the
other 3 — 5 years ago.
Tab. 4. Frequency of abnormalities of serum choline esterase activity (37 °C) in patients with various hepatic disease.
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Acetylthiocholine Butyrylthiocholine Propionylthiocholine



























































































A and B indicate the 0.5 and 0.6 activity fractions referred to the average normal values, respectively.
Figures in parentheses are the number fractions referred to the total patient numbers (No. of cases) in cach disease group.
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Clinical course of chronic hepatitis with abnormally
Iow choline esterase activity and hepatic cirrhosis with
relativcly higher choline esterase activity
In 8 of 50 patients with chronic hepatitis studied over
a period from January to December 1979 (tab. 2), a
lower value of choline esterase below 50% of the
average normal level with acetyl-, butyryl-, or pro-
pionyl-thiocholine was observed. A follow up study
of these patients showed that 6 of these 8 patients
had developed hepatic cirrhosis by 1982, resulting in
a poor prognosis.
In 7 out of 32 patients with hepatic cirrhosis studied
over the period from January to December 1979 (tab.
2), a higher choline esterase activity than 50% of
the average normal level with acetyl-, butyryl-, or
propionyl-thiocholine was observed. Of these, 3
patients had hepatic cirrhosis for a year, and l, 2,
and l patients for 2, 3, and 5 years, respectively.
Postnecrotic cirrhosis was seen in 5 patients and
alcoholic in 2. A follow up study indicated that 5 of
these 7 patients showed a progressive decrease in
activity and died by 1983. Of these 5 deaths, 4 were
due to bleeding from oesophageal varices and l due
to bacterial infection.
Discussion
For the determination of choline esterase activity,
various methods have developed with various choline
esters. The optimal pH for the assay varies with the
type and ionic strength of the buffer, with the sub-
strate concentration, and also with the enzyme vari^
ants (2, 25). The serum pseudocholine esterase had
an optimal pH of 8.5-9.0 with Substrates used under
the conditions of the present study, agreeing with the
results of previous workers (2, 25). However, a pH
of 7.5, äs used in the present work, is generally
preferred (2), because there is an apparent increase
in spontaneous hydrolysis of Substrate with in-
creasing pH (2).
Previous studies recommend an assay temperature of
37 °C, since a better Separation of phenotypes occurs
at 37 °C than at 25 °C (26-28). Similarly, in the
present study, 37 °C was superior to 25 °C for as-
sessing hepatic function when the assay was con-
ducted with a short incubation time, e. g. 5 min, be-
cause these conditions gave a better differentiation
of the decreased enzyme activity in hepatic cirrhosis.
However, at 25 °C, the decreased enzyme activity in
hepatic cirrhosis was well differentiated when longer
periods of incubation, such äs 10 min, were used,
Furthermore, in this study the decreased rates of
serum choline esterase activity in hepatic cirrhosis
measured at 25> 30, and 37 °C were not significantly
different. Therefore, if optimal assay conditions were
used, no significant difference was observed in the
results obtained either at 25, '30, or 37 °C with respect
to the assay of decreased serum choline esterase activ-
ity for the evaluation of liver disease.
Since butyrylthiocholine is the least labile of the
thiocholinesters and because it is relatively specific
for human serum pseudocholine esterase (2), it has
been recommended and used äs the Substrate of
choice for routine purposes (2,29 — 31). Furthermore,
otoluoylcholine has been reported to be äs stable äs
butyrylthiocholine and more specific for human
serum pseudocholine esterase than butyrylthiocholine
(15). Although propionylthiocholine is recommended
äs a better Substrate than butyrylthiocholine for the
differentiation of the phenotypes of pseudocholine
esterase (10 — 12), succinylcholine may be the most
suitable Substrate for direct detection of succinylcho-
line sensitivity (6).
With respect to the specificity of Substrates for meas-
uring serum pseudocholine esterase for the äs-
sessment of hepatic function, Prellwitz et al. (14) have
reported that in hepatic cirrhosis and also in chronic
hepatitis the activities of serum choline esterase deter-
mined at 25 °C with acetyl-, butyryl-, or propionyl-
thiocholine all showed similar decreases, and revealed
no significant differences ja the specificities of sub-
strates. Likewise, in the present study the decreased
choline esterase activity in hepatic cirrhosis was ob-
served with each of these Substrates. In the present
study, each of these Substrates revealed the same
decrease of enzyme activity when the assay was con-
ducted at 37 °C, thus confirming the finding of Pre-
llwitz et al at 25 °C. Furthermore, the serum choline
esterase activity determined with ö-toluoylcholine
and succinylcholine decreased at a similar rate cjom-
pared with the enzyme activity determined with acet-
yl-, butyryl-, and propionyl-thiocholine. Thus, the
present study indicates no significant diffefence in
specificity of various Substrates with respect to the
evaluation of hepatic function.
Under the conditions of the present study with acet-
yl-, butyryl-, and propionyl-thiocholine, and ö-to-
luoylcholine, in 78 — 84% of cases with hepatic cir-
rhosis the enzyme activity was less than 50% of
average levels of normal individuals, but in acute and
. chronic hepatitis only 4-9 and 12-14% of patients
showed the lower values, respectively. In 17 (53%)
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out of 32 hepatic cirrhosis patients, the onset of
disease was within the previous 2 years. Of these 17
patients, 13 (76%) had the lower values. These fin-
dings indicate the usefulness of the serum choline
esterase assay with any of these Substrates for as-
sessing chronic hepatic disease. Furthermore, the pre-
sent study suggests that succinylcholine is also useful
for evaluating hepatic function.
In addition, the present findings support the con-
tention that sequential measurement of the serum
choline esterase activity is valuable for monitoring
the course of hepatic disorders (3, 4, 32). The results
of the present study, together with several published
comments (3, 4, 32), suggest that reduction of choline
esterase activity to about one quarter of a given
patient's normal activity, usually heralds that
person's death.
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